Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fitim Berisha

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Scientific Reports|September 10, 2017
The Chemical Form of Metal Species Released from Corroded Taper Junctions of Hip Implants: Synchrotron Analysis of Patient TissueAnna Di Laura, Paul D Quinn, Vasiliki C Panagiotopoulou, et al.
Cancer Medicine|May 28, 2014
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapyM Fernanda Amary, Hongtao Ye, Fitim Berisha, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 6, 2019
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangementFernanda Amary, Luis Perez-Casanova, Hongtao Ye, et al.
The Journal of Pathology|May 21, 2011
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursM Fernanda Amary, Krisztian Bacsi, Francesca Maggiani, et al.
The Journal of Pathology|December 21, 2010
The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic targetAsem Shalaby, Nadège Presneau, Hongtao Ye, et al.
Nature Genetics|October 16, 2012
A common single-nucleotide variant in T is strongly associated with chordomaNischalan Pillay, Vincent Plagnol, Patrick S Tarpey, et al.
Nature Genetics|November 8, 2011
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2M Fernanda Amary, Stephen Damato, Dina Halai, et al.
Nature Communications|June 3, 2018
Recurrent rearrangements of FOS and FOSB define osteoblastomaMatthew W Fittall, William Mifsud, Nischalan Pillay, et al.
Cancer Cell|March 20, 2019
Undifferentiated Sarcomas Develop through Distinct Evolutionary PathwaysChristopher D Steele, Maxime Tarabichi, Dahmane Oukrif, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Scientific Reports|September 10, 2017
The Chemical Form of Metal Species Released from Corroded Taper Junctions of Hip Implants: Synchrotron Analysis of Patient TissueAnna Di Laura, Paul D Quinn, Vasiliki C Panagiotopoulou, et al.
Cancer Medicine|May 28, 2014
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapyM Fernanda Amary, Hongtao Ye, Fitim Berisha, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 6, 2019
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangementFernanda Amary, Luis Perez-Casanova, Hongtao Ye, et al.
The Journal of Pathology|May 21, 2011
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursM Fernanda Amary, Krisztian Bacsi, Francesca Maggiani, et al.
The Journal of Pathology|December 21, 2010
The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic targetAsem Shalaby, Nadège Presneau, Hongtao Ye, et al.
Nature Genetics|October 16, 2012
A common single-nucleotide variant in T is strongly associated with chordomaNischalan Pillay, Vincent Plagnol, Patrick S Tarpey, et al.
Nature Genetics|November 8, 2011
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2M Fernanda Amary, Stephen Damato, Dina Halai, et al.
Nature Communications|June 3, 2018
Recurrent rearrangements of FOS and FOSB define osteoblastomaMatthew W Fittall, William Mifsud, Nischalan Pillay, et al.
Cancer Cell|March 20, 2019
Undifferentiated Sarcomas Develop through Distinct Evolutionary PathwaysChristopher D Steele, Maxime Tarabichi, Dahmane Oukrif, et al.
Pageof 2